Abstract
Nanotechnology applications in neuroscience promises to deliver significant scientific and technological breakthroughs, providing answers to unresolved questions regarding the processes occurring in the brain. In this perspective, we provide a short background on two distinct fluorescent nanoparticles and summarize several studies focussed on achieving delivery of these into the brain and their interaction with brain tissue. Furthermore, we discuss challenges and opportunities for further development of nanoparticle-based therapies for targeting delivery of drugs across the blood-brain barrier.
Similar content being viewed by others
References
Abbott NJ (2013) Blood–brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36:437–449. doi:10.1007/s10545-013-9608-0
Aharonovich I, Greentree AD, Prawer S (2011) Diamond photonics Nat Photon 5:397–405
Alawdi SH, El-Denshary ES, Safar MM, Eidi H, David M-O, Abdel-Wahhab MA (2016) Neuroprotective effect of nanodiamond in Alzheimer’s disease rat model: a pivotal role for modulating NF-κB and STAT3 signaling molecular neurobiology:1–13
Aramesh M et al. (2015a) Ultra-high-density 3D DNA arrays within nanoporous biocompatible membranes for single-molecule-level detection and purification of circulating nucleic acids. Nanoscale 7:5998–6006
Aramesh M, Shimoni O, Ostrikov K, Prawer S, Cervenka J (2015b) Surface charge effects in protein adsorption on nanodiamonds. Nanoscale 7:5726–5736
Banks WA (2016) From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery. Nat Rev Drug Discov 15:275–292
Chang H-C (2010) Development and use of fluorescent nanodiamonds as cellular markers. In: Nanodiamonds. Springer, pp 127–150
Chang IP, Hwang KC, Ho J-aA, Lin C-C, Hwu RJR, Horng J-C (2010) Facile surface functionalization of nanodiamonds. Langmuir 26:3685–3689
Chen G, Qiu H, Prasad PN, Chen X (2014) Upconversion nanoparticles: design, nanochemistry, and applications in theranostics. Chem Rev 114:5161–5214
Chinen AB, Guan CM, Ferrer JR, Barnaby SN, Merkel TJ, Mirkin CA (2015) Nanoparticle probes for the detection of cancer biomarkers, cells, and tissues by fluorescence. Chem Rev 115:10530–10574
Eidi H et al. (2015) Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition. BMC medicine 13:144
Fu C-C et al. (2007) Characterization and application of single fluorescent nanodiamonds as cellular biomarkers. Proc Natl Acad Sci 104:727–732
Guan Y, Li M, Dong K, Ren J, Qu X (2014) NIR-responsive upconversion nanoparticles stimulate neurite outgrowth in PC12. Cells Small 10:3655–3661
Hsu T-C, Liu K-K, Chang H-C, Hwang E, Chao J-I (2014) Labeling of neuronal differentiation and neuron cells with biocompatible fluorescent nanodiamonds. Scientific Reports 4:5004
Huang Y-A et al. (2014) The effect of fluorescent nanodiamonds on neuronal survival and morphogenesis. Scientific Reports 4:6919
Jain KK (2012) Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine (London, England) 7:1225–1233
Jin JF, Xu ZH, Zhang Y, Gu YJ, Lam MHW, Wong WT (2013) Upconversion nanoparticles conjugated with Gd3 + −DOTA and RGD for targeted dual-modality imaging of brain tumor xenografts. Adv Healthc Mater 2:1501–1512
Khan Z et al. (2013) Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC medicine 11:1–18
Krueger A, Lang D (2012) Functionality is key: recent progress in the surface modification of nanodiamond. Adv Funct Mater 22:890–906
Lim E-K, Kim T, Paik S, Haam S, Huh Y-M, Lee K (2015) Nanomaterials for theranostics: recent advances and future challenges. Chem Rev 115:327–394
Liu K-K, Cheng C-L, Chang C-C, Chao JI (2007) Biocompatible and detectable carboxylated nanodiamond on human cell. Nanotechnology 18:325102
Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9:106–118
Lu Y et al. (2014) Tunable lifetime multiplexing using luminescent nanocrystals. Nat Photon 8:32–36
McGuinness LP et al. (2011) Quantum measurement and orientation tracking of fluorescent nanodiamonds inside living cells. Nat Nano 6:358–363
Meinhardt T, Lang D, Dill H, Krueger A (2011) Pushing the functionality of diamond nanoparticles to new horizons: orthogonally functionalized nanodiamond using click chemistry. Adv Funct Mater 21:494–500
Mochalin VN, Shenderova O, Ho D, Gogotsi Y (2012) The properties and applications of nanodiamonds. Nat Nano 7:11–23
Ni DL et al. (2014a) Single Ho3 + −doped upconversion nanoparticles for high-performance T-2-weighted brain tumor diagnosis and MR/UCL/CT multimodal imaging. Adv Funct Mater 24:6613–6620
Ni DL et al. (2014b) Dual-targeting upconversion Nanoprobes across the blood-brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma. ACS Nano 8:1231–1242
Peng J et al. (2015) High-efficiency in vitro and in vivo detection of Zn2+ by dye-assembled upconversion nanoparticles. J Am Chem Soc 137:2336–2342
Slegerova J, Hajek M, Rehor I, Sedlak F, Stursa J, Hruby M, Cigler P (2015) Designing the nanobiointerface of fluorescent nanodiamonds: highly selective targeting of glioma cancer cells. Nanoscale 7:415–420
Tong W et al. (2014) Fabrication of planarised conductively patterned diamond for bio-applications. Mater Sci Eng C 43:135–144
Vial S et al. (2008) Peptide-grafted nanodiamonds: preparation, cytotoxicity and uptake in cells. Chembiochem 9:2113–2119
Weiss N, Miller F, Cazaubon S, Couraud P-O (2009) The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta Biomembr 1788:842–857
Xi G et al. (2013) Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment. Nanomedicine: Nanotechnology, Biology and Medicine 10:381–391
Yokel RA (2016) Physicochemical properties of engineered nanomaterials that influence their nervous system distribution and effects. Nanomedicine: Nanotechnology, Biology and Medicine 12:2081–2093
Yu S-J, Kang M-W, Chang H-C, Chen K-M, Yu Y-C (2005) Bright fluorescent nanodiamonds: no photobleaching and low cytotoxicity. J Am Chem Soc 127:17604–17605
Zhang T-T, Li W, Meng G, Wang P, Liao W (2016) Strategies for transporting nanoparticles across the blood-brain barrier. Biomaterials Science 4:219–229
Zhao J et al. (2013) Single-nanocrystal sensitivity achieved by enhanced upconversion luminescence. Nat Nanotechnol 8:729–734
Zhou B, Shi B, Jin D, Liu X (2015) Controlling upconversion nanocrystals for emerging applications. Nat Nano 10:924–936
Acknowledgments
O.S. and B.S. are the recipients of an NHMRC-ARC Dementia Research Fellowships (APP1101258 and APP1111611). The Florey Institute of Neuroscience and Mental Health acknowledge the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shimoni, O., Shi, B., Adlard, P.A. et al. Delivery of Fluorescent Nanoparticles to the Brain. J Mol Neurosci 60, 405–409 (2016). https://doi.org/10.1007/s12031-016-0833-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-016-0833-5